Clinical Trials Sponsored by Humax Pharmaceutical
Total 22878 results
-
Jacobus PharmaceuticalTerminatedPemphigus VulgarisUnited States
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Zeria PharmaceuticalTerminated
-
JW PharmaceuticalNot yet recruiting
-
BioMarin PharmaceuticalRecruitingIdiopathic Short StatureUnited States
-
Xintian PharmaceuticalNot yet recruiting
-
JW PharmaceuticalRecruitingGoutKorea, Republic of
-
JW PharmaceuticalRecruitingType 2 Diabetes MellitusKorea, Republic of
-
JW PharmaceuticalRecruitingType 2 Diabetes MellitusKorea, Republic of
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States, Germany, Italy
-
BioMarin PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A With Anti Factor VIIIUnited States, United Kingdom, Taiwan, Israel, Korea, Republic of, South Africa, Brazil, Italy, Germany
-
Bukwang PharmaceuticalTerminatedParkinson Disease | DyskinesiasUnited States
-
Chugai PharmaceuticalActive, not recruitingCeliac DiseaseUnited States, Australia
-
BioMarin PharmaceuticalActive, not recruitingHemophilia A | Gene Therapy | Blood Disorder | Clotting DisordersTaiwan, Korea, Republic of, United Kingdom, South Africa
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Australia, Taiwan, Brazil
-
Kaken PharmaceuticalActive, not recruiting
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
JW PharmaceuticalCompletedHypertension | DyslipidemiaKorea, Republic of
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Japan, United Kingdom
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaAustralia, United Kingdom
-
Xintian PharmaceuticalCompletedErectile Dysfunction | Chronic Prostatitis With Chronic Pelvic Pain SyndromeChina
-
Allysta PharmaceuticalCompleted
-
Bukwang PharmaceuticalCompletedSchizophreniaKorea, Republic of
-
Bukwang PharmaceuticalCompletedCOVID-19Korea, Republic of
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
Chugai PharmaceuticalCompleted
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV AUnited States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, United Kingdom, Japan, Spain, Turkey
-
JW PharmaceuticalCompletedAnemia of Chronic Kidney DiseaseKorea, Republic of
-
Chugai PharmaceuticalCompletedHealthy VolunteersUnited Kingdom
-
BioMarin PharmaceuticalCompletedTetrahydrobiopterin Deficiencies | Hyperphenylalaninemia, Non-PhenylketonuricGermany, United States
-
JW PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States, Turkey, Canada, France, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis IVA (Morquio A Syndrome)Australia
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky DiseaseUnited States, Italy, Germany, United Kingdom
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Chugai PharmaceuticalCompletedHyperphosphatemiaUnited States
-
BioMarin PharmaceuticalCompletedPompe DiseaseUnited States, United Kingdom, France, Australia, Germany
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
BioMarin PharmaceuticalTerminatedPhenylketonuriaItaly, Switzerland
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, Italy, Sweden
-
BioMarin PharmaceuticalApproved for marketingCLN2 DiseaseUnited Kingdom, United States, Germany, Italy
-
Zeria PharmaceuticalCompletedDyspepsiaBelgium, Bulgaria, Latvia, Lithuania, Romania, Russian Federation, Slovakia, Sweden, Ukraine, United Kingdom
-
JW PharmaceuticalCompletedBenign Prostatic Hyperplasia | NocturiaKorea, Republic of
-
JW PharmaceuticalCompletedErectile DysfunctionKorea, Republic of